Benitec Biopharma
BNTC
BNTC
6 hedge funds and large institutions have $373K invested in Benitec Biopharma in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$166K |
| 2 |
2
Morgan Stanley
New York
|
$134K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$11K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $166K | 56,000 | +36,491 | +187% |
|
|
2
Morgan Stanley
New York
| $134K | 42,000 | +21,300 | +103% |
|
3
Renaissance Technologies
New York
| $44K | 13,700 | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $11K | 3,527 | -916 | -21% |
|
5
CIBC Private Wealth Group
Atlanta,
Georgia
| $10K | 3,000 | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $8K | 2,600 | – | – |
|